Make answers from all the main topic that i can read here and write in muhs exam 2nd year pharmac mbbs in easy language

Reading File
Running Command
Running Command
Running Command
Running Command
All 10 main topics from your PDF are covered above. Here's what's included:
#Topic
1Thyroid Hormones — Synthesis steps
2Antithyroid Drugs — Classification, Mechanism, Uses, ADR
3Thyroid Storm — Features + Full Treatment
4Insulin — Mechanism, Preparations, Indications, Complications
5Diabetic Ketoacidosis (DKA) — Management
6Oral Antidiabetic Drugs — All classes (Sulphonylureas, Metformin, Pioglitazone, Acarbose)
7Corticosteroids — Actions, Adverse Effects, All Therapeutic Uses
8Hormonal Contraceptives — Combined pill, Mini pill, Emergency pill, Injectables
9Uterine Relaxants (Tocolytics)
10Uterine Stimulants — Oxytocin in detail
Tips for MUHS exam:
  • The memory mnemonics from your notes (like PYARA PATI, SITA ALOK LINA, BMW) are already incorporated
  • For 10-mark questions: write headings clearly — Classification → MOA → PK → Uses → ADR
  • The "Quick Revision Table" at the end is perfect for last-minute reading before the exam

Make important point notes from the pdf on all topics Make it into easy language Write it here dont make docx

Here are all the important point notes from your PDF — simple, crisp, exam-ready:

📝 HORMONES PHARMACOLOGY — IMPORTANT POINT NOTES

MUHS 2nd Year MBBS


🔵 TOPIC 1: THYROID HORMONES

Hormones of thyroid gland: T3, T4, Calcitonin
Synthesis Steps — Remember: TOIHR
  • T — Trapping (iodide taken into follicular cells via NIS — sodium/iodide symporter)
  • O — Oxidation (iodide → iodine by peroxidase)
  • I — Iodination (iodine + tyrosine → MIT and DIT)
  • H — Hormone formation / Coupling (MIT+DIT = T3 / DIT+DIT = T4) — by thyroid peroxidase
  • R — Release (controlled by TSH; endocytosis + proteolysis of thyroglobulin)
Key points:
  • Most hormone released from thyroid is T4 (less potent)
  • T4 → T3 conversion occurs in liver and kidney
  • T3 is more potent than T4

🔵 TOPIC 2: ANTITHYROID DRUGS

Classification (easy):

  • Block synthesis → Thioamides (PTU, Methimazole, Carbimazole)
  • Block iodide trapping → Ionic inhibitors (Thiocyanate, Perchlorate, Nitrate)
  • Block hormone release → Iodine/Iodides (Lugol's iodine, KI)
  • Destroy thyroid tissue → Radioactive iodine (¹³¹I)

A) THIOAMIDES — PTU, Methimazole, Carbimazole

3 actions (all block thyroid peroxidase):
  1. Iodide → Iodine conversion blocked
  2. Iodination of tyrosine blocked
  3. Coupling of MIT + DIT blocked
Extra action of PTU only:
  • Also blocks peripheral T4 → T3 conversion (that's why PTU used in thyroid storm)
Pharmacokinetics — key points:
  • All well absorbed orally
  • Carbimazole is a prodrug → converted to methimazole in body
  • Accumulate in thyroid gland
Adverse effects:
  • Skin rashes — most common
  • Agranulocytosis — rare but dangerous
  • Joint pain, fever, hepatitis, nephritis
Uses — 4 important:
  1. Long-term hyperthyroidism (Graves' disease, toxic nodular goitre)
  2. Preoperatively before thyroidectomy → to make patient euthyroid
  3. With radioactive iodine → for initial control (¹³¹I is slow)
  4. Thyroid storm (PTU preferred)
Which one to prefer?
  • Carbimazole/Methimazole preferred for long-term → long acting, not hepatotoxic
  • PTU preferred in thyroid storm and pregnancy (crosses placenta less)

B) IODINE AND IODIDES

Key points:
  • Oldest antithyroid agents
  • Most rapid acting antithyroid drugs
  • Preparations: Lugol's iodine (5% iodine + 10% KI), Ipodate sodium, Iopanoic acid
Uses:
  • Preoperatively before thyroidectomy (makes gland firm, small, less vascular → less bleeding during surgery)
  • Thyroid storm
  • KI as expectorant (mucolytic)
  • Tincture of iodine as antiseptic
  • Iodized salt → prophylaxis of endemic goitre
Adverse effects:
  • Type III hypersensitivity → angioedema, laryngeal oedema, arthralgia, fever, eosinophilia

C) RADIOACTIVE IODINE (¹³¹I)

  • ¹³¹I half-life = 8 days → therapeutic use
  • ¹²³I half-life = 13 hours → diagnostic scan
Uses:
  • Hyperthyroidism (Graves' disease, toxic nodular goitre) — especially elderly + cardiac patients
  • Adenoma/carcinoma when surgery not feasible
Contraindications: Pregnancy, children, nursing mothers
Advantages: Outpatient, cheap, no surgery, permanent cure Disadvantages: Slow acting, high incidence of hypothyroidism, soreness in neck

🔵 TOPIC 3: THYROID STORM (THYROID CRISIS)

What is it? Severe hypermetabolic state due to very high thyroid hormones in blood
Features = usual hyperthyroidism + extra 4:
  • Hyperpyrexia (very high fever)
  • Cardiac arrhythmias (atrial fibrillation)
  • Nausea, vomiting, diarrhoea
  • Mental confusion / coma
Precipitating factors: Infection, trauma, surgery, DKA, MI
Treatment (6 steps):
  1. Hospitalization + supportive care (cooling, hydration, sedation, antibiotics)
  2. Propranolol IV 1-2 mg every 4 hours → controls tachycardia, tremors; blocks T4→T3 conversion
  3. PTU via nasogastric tube → blocks synthesis + T4→T3 conversion
  4. Sodium ipodate 0.5 g orally → blocks hormone release + T4→T3 conversion
  5. Diltiazem → if propranolol is contraindicated
  6. Hydrocortisone 100 mg IV every 8 hrs → blocks T4→T3; corrects adrenal insufficiency

🔵 TOPIC 4: INSULIN

Basic Facts:

  • Made by β-cells of pancreatic islets
  • Route: preproinsulin → proinsulin → insulin (C-peptide removed)
  • Structure: A chain + B chain connected by 2 disulphide bridges

Actions:

  • ↑ glucose uptake, glycogen synthesis, protein synthesis, lipogenesis
  • ↓ gluconeogenesis, glycogenolysis, lipolysis, ketogenesis

Mechanism of Action:

  • Receptor = Tyrosine kinase receptor (2α + 2β subunits)
  • α subunit = extracellular (binds insulin)
  • β subunit = transmembrane with tyrosine kinase activity
  • Binding → tyrosine kinase activation → phosphorylation cascade → glucose enters cell

Pharmacokinetics:

  • Destroyed in gut → NOT oral
  • Route: SC (subcutaneous) usually; IV only in emergencies (regular insulin)
  • Half-life after IV = ~6 minutes (liver + kidney metabolize)

Insulin Preparations (by duration):

TypeExampleOnsetPeakDuration
Rapid-actingLispro, Aspart, Glulisine5-15 min1 hr3-4 hr
Short-actingRegular (Soluble)30 min2-3 hr6-8 hr
IntermediateNPH1-2 hr4-8 hr12-18 hr
Long-actingGlargine, Detemir1-2 hrNo peak20-24 hr
Memory: Rapid-lag, Short-soluble, Long-gaal
Concentrations: 40 U/mL or 100 U/mL; Regular also in 500 U/mL

Indications:

  1. Type 1 DM (all patients, always)
  2. DKA
  3. Non-ketotic hyperglycaemic coma
  4. Diabetes in pregnancy
  5. Stress (surgery, infection, trauma) in diabetics
  6. Type 2 DM when oral drugs fail

Site of Injection (SC): Abdomen, buttock, anterior thigh, dorsal arm

Complications:

ComplicationKey point
HypoglycaemiaMost common + most dangerous; prolonged → brain damage
Allergic reactionsLocal skin reactions; rare
LipodystrophyAtrophy/hypertrophy at site; prevent by rotating injection sites
OedemaSalt and water retention

🔵 TOPIC 5: DIABETIC KETOACIDOSIS (DKA)

Occurs in: Type 1 DM (rare in Type 2)
Precipitants: Infection, trauma, severe stress
Features:
  • Anorexia, nausea, vomiting
  • Polyuria, abdominal pain
  • Hypotension, tachycardia
  • Kussmaul breathing (hyperventilation)
  • Altered consciousness → coma
Management — 6 steps:
  1. Insulin — Regular insulin IV bolus 0.2–0.3 U/kg → then 0.1 U/kg/hr infusion
    • Blood glucose should ↓ by 10% in first hour
    • Once conscious → shift to SC insulin
  2. Fluids — Normal saline 1 L/hr → reduce gradually
    • When blood glucose reaches ~250 mg/dL → switch to 5% dextrose + normal saline (prevents hypoglycaemia + cerebral oedema)
  3. Potassium — After insulin, K⁺ shifts into cells → hypokalaemia
    • Give KCl 10–20 mEq/hr after 4 hours of insulin
    • Monitor serum K⁺ and ECG
  4. Sodium bicarbonate — IV if severe acidosis
  5. Phosphate — If severe hypophosphataemia
  6. Antibiotics — For associated infection

🔵 TOPIC 6: ORAL ANTIDIABETIC DRUGS

Classification (Simple):

ClassDrugsAction
SulphonylureasTolbutamide, Glibenclamide, Glipizide, Gliclazide, Glimepiride↑ insulin secretion
BiguanidesMetformin↓ gluconeogenesis, ↑ insulin sensitivity
ThiazolidinedionesPioglitazone↑ insulin sensitivity
α-Glucosidase inhibitorsAcarbose, Miglitol, Voglibose↓ carbohydrate absorption
MeglitinidesRepaglinide, Nateglinide↑ insulin secretion
DPP-4 inhibitorsSitagliptin, Vildagliptin, Linagliptin↑ incretin effect
SGLT-2 inhibitorsDapagliflozin↑ glucose excretion in urine

A) SULPHONYLUREAS

Mechanism: Block K⁺-ATP channels in β-cells → depolarization → Ca²⁺ influx → insulin secretion (insulin secretagogue)
Adverse effects — 5 important:
  1. Hypoglycaemia — MC complication (especially glibenclamide, chlorpropamide — long acting); avoid glibenclamide in elderly
  2. GI disturbances (nausea, vomiting, flatulence)
  3. Weight gain
  4. Skin rashes, photosensitivity
  5. Teratogenic — NOT safe in pregnancy
Use: Type 2 DM only

B) METFORMIN (Biguanide)

Mechanism — 3 actions:
  1. Activates AMPK → ↓ hepatic gluconeogenesis (main action)
  2. ↑ peripheral glucose utilization in muscle and fat
  3. ↓ intestinal absorption of glucose
  • Does NOT stimulate insulin secretion → improves insulin sensitivity
Adverse effects:
  • Metallic taste, nausea, vomiting, diarrhoea, weight loss
  • Lactic acidosis — most serious (rare)
  • Vitamin B12 deficiency — on prolonged use (malabsorption)
  • Does NOT cause hypoglycaemia
Key advantages:
  • Drug of choice in obese Type 2 DM
  • Protects against vascular complications
  • No hypoglycaemia

C) PIOGLITAZONE (Thiazolidinedione)

Mechanism: Activates PPAR-γ → ↑ insulin sensitivity in tissues
Adverse effects: Oedema, weight gain, anaemia, heart failure, hepatotoxicity (rare), bladder cancer (rare)

D) ACARBOSE (α-Glucosidase inhibitor)

Mechanism: Blocks α-glucosidase enzyme in small intestine brush border → ↓ carbohydrate digestion → ↓ postprandial hyperglycaemia
Key points:
  • Must be taken just before food
  • Best for obese Type 2 DM patients
  • Side effects: flatulence, fullness, diarrhoea (all GI — because undigested carbs ferment in colon)

🔵 TOPIC 7: CORTICOSTEROIDS

Classification:

  • Short acting: Hydrocortisone (Cortisol)
  • Intermediate acting: Prednisolone, Methylprednisolone, Triamcinolone, Deflazacort
  • Long acting: Dexamethasone, Betamethasone
  • Mineralocorticoids: Aldosterone, Fludrocortisone, DOCA

Pharmacological Actions:

1. Carbohydrate → ↑ glycogen in liver, ↑ gluconeogenesis, ↓ peripheral glucose use → hyperglycaemia
2. Fat → Redistribution → Moon face, buffalo hump, fish mouth, thin limbs (Cushing's look)
3. Protein → Catabolic → breakdown of muscle, bone, skin → muscle wasting, thin skin, osteoporosis, growth retardation, poor wound healing
4. Electrolytes → Na⁺ + water retention, K⁺ loss → oedema, hypertension
  • Dexamethasone, betamethasone, triamcinoloneNO Na⁺ retention
5. Calcium → Anti-Vitamin D effect → ↓ Ca²⁺ absorption, ↑ renal excretion, ↑ osteoclast activity → osteoporosis, pathological fractures
6. CVS → Na⁺ retention → hypertension; permissive effect on adrenaline/angiotensin
7. Muscle → Required for normal function; weakness in both hypo and hypercorticism
8. GIT → Inhibit PGs → ↑ gastric acid + pepsin → aggravate peptic ulcer
9. Anti-inflammatory → Via lipocortin → inhibit phospholipase A₂ → ↓ arachidonic acid → ↓ PGs + LTs

Adverse Effects — Remember "COME BUGS":

  • C — Cushing's (moon face, buffalo hump)
  • O — Osteoporosis + fractures
  • M — Muscle weakness, myopathy
  • E — Electrolyte changes (Na⁺↑, K⁺↓), oedema
  • B — Blood sugar ↑ (diabetes aggravated)
  • U — Ulcer (peptic)
  • G — Growth retardation in children; Glaucoma + cataract
  • S — Suppression of immunity → infections (TB reactivation, candidiasis, herpes)
(Also: CNS effects — insomnia, mood changes, psychosis)

Therapeutic Uses — All 14:

  1. Rheumatoid arthritis — symptomatic relief (doesn't stop progression)
  2. Osteoarthritis — intra-articular injection
  3. Rheumatic fever with carditis + CCF
  4. Gout — reserve drug (when NSAIDs fail)
  5. Allergic diseases — hay fever, urticaria, angioedema, anaphylaxis
  6. Bronchial asthma — IV hydrocortisone (acute); inhaled beclomethasone/budesonide (chronic)
  7. Collagen diseases — polymyositis, polyarteritis nodosa, dermatomyositis
  8. Nephrotic syndrome — first-line drug
  9. Ocular diseases — topical/subconjunctival/systemic
  10. Skin diseases — topical preferred
  11. Haematological — autoimmune haemolytic anaemia; lymphomas, leukaemia, Hodgkin's, myeloma
  12. Cerebral oedema — very effective for brain tumours, metastasis, TB meningitis; least effective in head injury
  13. Ulcerative colitis — methylprednisolone retention enema
  14. Septic shock — prompt IV glucocorticoids may be life-saving

🔵 TOPIC 8: HORMONAL CONTRACEPTIVES

Types:

  • Combined pill (Oestrogen + Progestin)
  • Mini pill (Progestin only)
  • Emergency/Postcoital pill
  • Injectable

Combined Pill — Schedule:

  • 1 tablet daily for 21 days → 7-day gap → repeat
  • Efficacy: 98–99.9%

Mini Pill — Schedule:

  • 1 tablet daily continuously (no gap)
  • Efficacy: 96%

Mechanism of Combined Pill — 4 ways:

  1. ↓ FSH + LH by negative feedback on hypothalamus-pituitary → no ovulation (main action)
  2. Tubal + uterine contractions → interfere with fertilization
  3. Endometrium made unsuitable for implantation
  4. Progestin → thick cervical mucus → blocks sperm penetration

Emergency Contraception (Morning After Pill):

  • Used within 72 hours of unprotected intercourse
  • Levonorgestrel 0.75 mg × 2 doses (most common)
  • Mifepristone 600 mg single dose (antiprogestin)
  • Ulipristal — can be used up to 120 hours
  • Mechanism: interferes with implantation + anti-ovulatory

Beneficial Effects:

Contraceptive: Prevents unwanted pregnancy
Non-contraceptive:
  • ↓ Dysmenorrhoea + premenstrual tension
  • ↓ Iron deficiency anaemia (less menstrual loss)
  • ↓ Pelvic inflammatory disease + endometriosis
  • ↓ Risk of ovarian and endometrial cancer ✅

Adverse Effects:

  • Early: Nausea, vomiting, headache, breakthrough bleeding
  • Late: Weight gain, fluid retention, acne, skin pigmentation, BP ↑
  • Serious (long-term): Venous thromboembolism (especially smokers), risk of MI + stroke (in diabetes/hypertension), gallstones, breast cancer, benign liver tumours
  • Impaired glucose tolerance (rare with low-dose)

Injectable Contraceptives:

DrugDose + Frequency
DMPA (Depot medroxyprogesterone acetate)150 mg IM every 3 months
NET-EN (Norethindrone enanthate)200 mg IM every 2 months
Advantages: No daily pill, safe during lactation, ↓ endometrial cancer
Disadvantages: Menstrual irregularities, headache, mood changes, weight gain, osteoporosis, ↓HDL/↑LDL, fertility returns after 6–8 months delay

🔵 TOPIC 9: UTERINE RELAXANTS (TOCOLYTICS)

Definition: Drugs that relax uterus and delay/stop premature labour

Classification:

  • β₂-agonists: Ritodrine, Salbutamol, Terbutaline, Isoxsuprine
  • Calcium channel blockers: Nifedipine
  • Oxytocin antagonist: Atosiban
  • Others: Magnesium sulfate, Progesterone, Nitrates, Halothane

Uses:

  1. Preterm labour — to delay it
  2. Threatened abortion
  3. Dysmenorrhoea

β₂-agonists — Key Points:

  • Adverse effects: Tachycardia, palpitations, arrhythmias, pulmonary oedema, hyperglycaemia, hypokalaemia
  • Avoid in: Pregnant women with diabetes or heart disease

NSAIDs (Indomethacin) as tocolytic:

  • Blocks PG synthesis → uterine relaxation
  • NOT used for preterm labour → risk of premature closure of ductus arteriosus → pulmonary hypertension
  • OK for dysmenorrhoea only

🔵 TOPIC 10: UTERINE STIMULANTS (OXYTOCICS)

Classification:

  • Posterior pituitary: Oxytocin, Desamino-oxytocin
  • Ergot alkaloids: Ergometrine, Methylergometrine
  • Prostaglandins: PGE₂ (Dinoprostone), PGF₂α (Dinoprost), Carboprost (15-methyl PGF₂α), Misoprostol
  • Others: Ethacridine, Quinine

OXYTOCIN — Most Important

Where is it made? Hypothalamus → stored in neurohypophysis (posterior pituitary)
Actions on 4 organs:
OrganEffect
UterusContracts pregnant uterus; sensitivity ↑ by oestrogen, ↓ by progesterone
BreastContracts myoepithelial cells → milk ejection
KidneyHigh dose → ADH-like effect → ↓ urine → water intoxication
CVSHigh dose → vasodilation, hypotension → reflex tachycardia, flushing
Mechanism:
  • Binds to G-protein coupled receptor on myometrium
  • → ↑ IP₃ → releases Ca²⁺ from intracellular stores
  • → ↑ PG production by endometrium
  • → Uterine contraction

Uses of Oxytocin — 4 main:

1. Induction of labourDrug of choice
  • Given by IV infusion
  • Start low dose, monitor and adjust
  • Monitor: uterine contractions, BP, fetal + maternal heart rate
2. Postpartum Haemorrhage (PPH) — prevention and treatment
  • Contracts uterine muscle → compresses blood vessels → stops bleeding
  • Preferred over ergot derivatives (fewer side effects)
  • Given IM (prevention) or IV infusion (treatment)
3. Uterine inertia — IV infusion to strengthen weak contractions during labour
4. Breast engorgement — intranasal oxytocin → milk let-down (↑ milk ejection)

⚡ SUPER QUICK REVISION — ALL TOPICS

Topic3 Most Important Points
Thyroid synthesisNIS traps iodide → peroxidase oxidizes → coupling makes T3/T4
ThioamidesBlock peroxidase; PTU also blocks T4→T3; carbimazole preferred long-term
Radioactive iodine¹³¹I, half-life 8 days; elderly/cardiac patients; CI in pregnancy
Thyroid stormPropranolol + PTU + Sodium ipodate + Hydrocortisone
InsulinTyrosine kinase receptor; SC route; hypoglycaemia = MC complication
DKAType 1 DM; IV regular insulin + NS; add 5% dextrose when BG ~250; KCl after 4 hrs
SulphonylureasK⁺-ATP channel blockers → ↑ insulin; hypoglycaemia MC; NOT in pregnancy
MetforminAMPK activator; ↓ gluconeogenesis; no hypoglycaemia; lactic acidosis rare
CorticosteroidsLipocortin inhibits phospholipase A₂; Cushing's, osteoporosis, peptic ulcer = ADR
Combined pill↓ FSH/LH (no ovulation); 21 days on, 7 off; 99% efficacy
Emergency pillLevonorgestrel within 72 hrs OR mifepristone single dose
Tocolyticsβ₂-agonists (ritodrine, salbutamol); indomethacin NOT used (closes ductus)
OxytocinHypothalamus made; IP₃ → Ca²⁺ → contraction; DOC for induction of labour + PPH

📌 Exam formula: Classification → Mechanism → Uses → Adverse Effects = full marks on any question

Make topics important points in short

⚡ HORMONES PHARMACOLOGY — SHORT IMPORTANT POINTS


🔵 1. THYROID HORMONES

  • Thyroid makes T3, T4, Calcitonin
  • Synthesis steps: Trapping → Oxidation → Iodination → Coupling → Release
  • Iodide trapped by NIS (sodium/iodide symporter)
  • Oxidation by peroxidase enzyme
  • Coupling: MIT+DIT = T3, DIT+DIT = T4
  • Most hormone released = T4 (less potent)
  • T4 → T3 conversion in liver and kidney
  • T3 is more potent than T4

🔵 2. ANTITHYROID DRUGS

Thioamides (PTU, Methimazole, Carbimazole)

  • Block thyroid peroxidase → no iodination, no coupling
  • PTU only → also blocks peripheral T4→T3 conversion
  • Carbimazole = prodrug → converts to methimazole
  • All accumulate in thyroid gland
  • ADR: Skin rashes (MC), agranulocytosis, hepatitis
  • Carbimazole preferred for long-term (not hepatotoxic)
  • PTU preferred in thyroid storm + pregnancy

Iodine/Iodides

  • Oldest + most rapid acting antithyroid drugs
  • Used preoperatively → makes gland firm, small, less vascular
  • KI = expectorant; Tincture iodine = antiseptic; Iodized salt = endemic goitre prevention
  • ADR: Type III hypersensitivity (angioedema, laryngeal oedema)

Radioactive Iodine (¹³¹I)

  • Half-life = 8 days (therapeutic); ¹²³I = 13 hrs (diagnostic)
  • Used in elderly + cardiac patients
  • CI: Pregnancy, children, nursing mothers
  • Advantage: Permanent cure, no surgery
  • Disadvantage: Slow, high incidence of hypothyroidism

🔵 3. THYROID STORM

  • Severe hyperthyroidism with hyperpyrexia, atrial fibrillation, mental confusion
  • Precipitants: infection, trauma, surgery, DKA, MI

Treatment:

  1. Hospitalization + supportive care
  2. Propranolol → controls tachycardia + blocks T4→T3
  3. PTU via NG tube
  4. Sodium ipodate → blocks release + T4→T3
  5. Diltiazem if propranolol contraindicated
  6. Hydrocortisone 100 mg IV 8 hrly → blocks T4→T3 + corrects adrenal insufficiency

🔵 4. INSULIN

  • Made by β-cells of pancreas; preproinsulin → proinsulin → insulin (C-peptide removed)
  • A chain + B chain joined by 2 disulphide bridges
  • Destroyed in gut → NOT oral; given SC (IV only in emergency)
  • Receptor = Tyrosine kinase receptor (2α + 2β subunits)
  • Half-life IV = ~6 min

Preparations:

TypeExampleDuration
RapidLispro, Aspart3-4 hr
ShortRegular/Soluble6-8 hr
IntermediateNPH12-18 hr
LongGlargine20-24 hr

Indications:

  • Type 1 DM, DKA, pregnancy, stress (surgery/infection), Type 2 DM (oral drugs failed)

Complications:

  • Hypoglycaemia — MC + most dangerous
  • Lipodystrophy — rotate injection sites to prevent
  • Allergic reactions, oedema

🔵 5. DIABETIC KETOACIDOSIS (DKA)

  • Complication of Type 1 DM
  • Features: vomiting, polyuria, Kussmaul breathing, hypotension, coma

Management:

  1. Regular insulin IV — 0.2-0.3 U/kg bolus → 0.1 U/kg/hr infusion
  2. Normal saline 1 L/hr → when BG ~250 switch to 5% dextrose + NS
  3. KCl 10-20 mEq/hr after 4 hrs (insulin causes hypokalaemia)
  4. Sodium bicarbonate if severe acidosis
  5. Antibiotics for infection

🔵 6. ORAL ANTIDIABETIC DRUGS

Sulphonylureas (Glibenclamide, Glipizide, Glimepiride)

  • Block K⁺-ATP channels → insulin secretion (secretagogue)
  • ADR: Hypoglycaemia (MC — especially glibenclamide, avoid in elderly), weight gain, teratogenic
  • NOT safe in pregnancy

Metformin (Biguanide)

  • Activates AMPK → ↓ hepatic gluconeogenesis (main)
  • No hypoglycaemia
  • ADR: Metallic taste, GI upset, lactic acidosis (rare), Vit B12 deficiency (long-term)
  • DOC in obese Type 2 DM

Pioglitazone (Thiazolidinedione)

  • Activates PPAR-γ → ↑ insulin sensitivity
  • ADR: Oedema, heart failure, bladder cancer (rare)

Acarbose (α-Glucosidase inhibitor)

  • Blocks α-glucosidase → ↓ carbohydrate absorption → ↓ postprandial sugar
  • Taken just before food
  • ADR: Flatulence, diarrhoea (only GI)

🔵 7. CORTICOSTEROIDS

Classification:

  • Short: Hydrocortisone
  • Intermediate: Prednisolone, Methylprednisolone
  • Long: Dexamethasone, Betamethasone
  • Mineralocorticoid: Aldosterone, Fludrocortisone

Key Actions:

  • Carbohydrate → ↑ gluconeogenesis → hyperglycaemia
  • Fat → Moon face, buffalo hump, thin limbs
  • Protein → Catabolic → muscle wasting, osteoporosis, poor wound healing
  • Electrolytes → Na⁺ + water retention, K⁺ loss (Dexamethasone has NO Na⁺ retention)
  • Calcium → Anti-Vit D → osteoporosis, fractures
  • Anti-inflammatory → via lipocortin → inhibits phospholipase A₂ → ↓ PGs + LTs

Adverse Effects (COME BUGS):

  • C — Cushing's (moon face, hump)
  • O — Osteoporosis
  • M — Muscle weakness
  • E — Electrolyte imbalance + oedema
  • B — Blood sugar ↑
  • U — Ulcer (peptic)
  • G — Growth retardation; Glaucoma + cataract
  • S — Suppressed immunity → TB reactivation, candidiasis, herpes

Important Uses:

  • Nephrotic syndrome — first-line
  • Bronchial asthma — IV hydrocortisone (acute); inhaled beclomethasone (chronic)
  • Cerebral oedema — best for tumours/TB meningitis; least for head injury
  • Septic shock — life-saving IV glucocorticoids
  • Rheumatoid arthritis, allergic diseases, haematological malignancies

🔵 8. HORMONAL CONTRACEPTIVES

Combined Pill (Oestrogen + Progestin)

  • Mechanism: ↓ FSH + LH → no ovulation (main); thick cervical mucus; hostile endometrium
  • Schedule: 21 days on → 7 days gap → repeat
  • Efficacy: 98–99.9%

Mini Pill (Progestin only)

  • Continuous — no gap; Efficacy: 96%

Emergency Pill (within 72 hrs):

  • Levonorgestrel 0.75 mg × 2 doses
  • Mifepristone 600 mg single dose
  • Mechanism: interferes with implantation + blocks ovulation

Non-contraceptive Benefits:

  • ↓ Dysmenorrhoea, ↓ anaemia, ↓ PID, ↓ ovarian + endometrial cancer

Adverse Effects:

  • Early: Nausea, headache, breakthrough bleeding
  • Late: Weight gain, acne, BP ↑
  • Serious: Venous thromboembolism (smokers), MI, stroke, breast cancer

Injectable:

  • DMPA — 150 mg IM every 3 months
  • NET-EN — 200 mg IM every 2 months
  • Fertility returns after 6–8 months delay

🔵 9. UTERINE RELAXANTS (TOCOLYTICS)

  • Uses: Preterm labour, threatened abortion, dysmenorrhoea

Drugs:

  • β₂-agonists: Salbutamol, Ritodrine, Terbutaline — ADR: tachycardia, pulmonary oedema, hyperglycaemia, hypokalaemia; avoid in diabetes + heart disease
  • Nifedipine (Ca²⁺ channel blocker)
  • Atosiban (oxytocin antagonist)
  • Magnesium sulfate, Progesterone

NSAIDs (Indomethacin):

  • Tocolytic but NOT used for preterm labour
  • Risk: premature closure of ductus arteriosus → pulmonary hypertension
  • OK only for dysmenorrhoea

🔵 10. UTERINE STIMULANTS (OXYTOCICS)

Classification:

  • Posterior pituitary: Oxytocin
  • Ergot alkaloids: Ergometrine, Methylergometrine
  • Prostaglandins: Misoprostol, Dinoprostone, Carboprost

Oxytocin — Key Points:

  • Made in hypothalamus, stored in posterior pituitary
  • Mechanism: G-protein receptor → IP₃ → Ca²⁺ release → uterine contraction
  • Oestrogen sensitivity; Progesterone sensitivity

4 Actions:

  • Uterus → contracts pregnant uterus
  • Breast → milk ejection (myoepithelial cells)
  • Kidney (high dose) → ADH-like → water intoxication
  • CVS (high dose) → vasodilation → hypotension → reflex tachycardia

Uses:

  1. Induction of labourDOC → IV infusion, low dose, monitor carefully
  2. PPH — prevention (IM) + treatment (IV); preferred over ergot
  3. Uterine inertia — strengthen weak contractions
  4. Breast engorgement — intranasal → milk let-down

🟡 FINAL FLASH POINTS

DrugMost Important Fact
PTUOnly drug that blocks both synthesis AND T4→T3 conversion
CarbimazoleProdrug; preferred long-term
¹³¹ICI in pregnancy; hypothyroidism is main ADR
Regular insulinOnly insulin given IV; DOC in DKA
GlibenclamideAvoid in elderly — prolonged hypoglycaemia
MetforminNo hypoglycaemia; B12 deficiency on long use
AcarboseTake before food; only GI side effects
DexamethasoneNo Na⁺ retention; causes growth retardation
HydrocortisoneDOC in septic shock; acute asthma IV
OxytocinDOC induction of labour + PPH
LevonorgestrelEmergency pill — within 72 hrs
DMPA150 mg IM every 3 months
IndomethacinNOT for preterm labour — closes ductus arteriosus
This is a shared conversation. Sign in to Orris to start your own chat.